MrBad
10-26-2008, 12:54 PM
I bought into this biotech company last week. It is now trading around 0.10 a share after it announced termination of Phase III trials on Oct. 16th. The stock, according to its assets and current cash position is well over 50% undervalued (100% gain potential) as the downside appears to have hit bottom.
What I found to be interesting was that on Friday after market closed, they annoucned the removal of 26million in debt at a 60% discount..... This saved them over 15Million in cash.... Ironically that is more than their current market cap. They still have a significant cash position over 100million.
The future of the company is yet to be determined as their main product was haulted in PIII trials, but there are ongoing trials being conducted through other collaborators. I personally feel the crisis market conditions have contributed to the current share price. Liquidation of all their asstes leaves them with at about 0.37 cents a share... so it seems a safe bet at the current share price. We shall see.
Good Luck to you all.
What I found to be interesting was that on Friday after market closed, they annoucned the removal of 26million in debt at a 60% discount..... This saved them over 15Million in cash.... Ironically that is more than their current market cap. They still have a significant cash position over 100million.
The future of the company is yet to be determined as their main product was haulted in PIII trials, but there are ongoing trials being conducted through other collaborators. I personally feel the crisis market conditions have contributed to the current share price. Liquidation of all their asstes leaves them with at about 0.37 cents a share... so it seems a safe bet at the current share price. We shall see.
Good Luck to you all.